Geode Capital Management, LLC Enanta Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 477,351 shares of ENTA stock, worth $4.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
477,351
Previous 462,776 3.15%
Holding current value
$4.55 Million
Previous $6 Million 17.53%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$10.05 - $16.54 $146,478 - $241,070
14,575 Added 3.15%
477,351 $4.95 Million
Q2 2024

Aug 09, 2024
BUY
$11.43 - $17.02 $236,646 - $352,382
20,704 Added 4.68%
462,776 $6 Million
Q1 2024

May 13, 2024
BUY
$10.08 - $17.46 $129,376 - $224,099
12,835 Added 2.99%
442,072 $7.72 Million
Q4 2023

Feb 13, 2024
BUY
$8.18 - $10.78 $159,812 - $210,608
19,537 Added 4.77%
429,237 $4.04 Million
Q3 2023

Nov 13, 2023
BUY
$11.09 - $22.13 $65,397 - $130,500
5,897 Added 1.46%
409,700 $4.58 Million
Q2 2023

Aug 11, 2023
BUY
$20.68 - $39.85 $180,474 - $347,770
8,727 Added 2.21%
403,803 $8.64 Million
Q1 2023

May 15, 2023
BUY
$38.82 - $54.59 $626,360 - $880,809
16,135 Added 4.26%
395,076 $16 Million
Q4 2022

Feb 13, 2023
BUY
$40.77 - $53.73 $650,689 - $857,530
15,960 Added 4.4%
378,941 $17.6 Million
Q3 2022

Nov 14, 2022
BUY
$48.29 - $71.27 $806,877 - $1.19 Million
16,709 Added 4.83%
362,981 $18.8 Million
Q2 2022

Aug 12, 2022
SELL
$38.13 - $76.93 $245,709 - $495,736
-6,444 Reduced 1.83%
346,272 $16.4 Million
Q1 2022

May 13, 2022
BUY
$56.06 - $74.11 $936,650 - $1.24 Million
16,708 Added 4.97%
352,716 $25.1 Million
Q4 2021

Feb 11, 2022
BUY
$60.19 - $97.37 $133,320 - $215,674
2,215 Added 0.66%
336,008 $25.1 Million
Q3 2021

Nov 12, 2021
BUY
$41.02 - $58.65 $138,811 - $198,471
3,384 Added 1.02%
333,793 $19 Million
Q2 2021

Aug 13, 2021
BUY
$43.76 - $53.11 $781,772 - $948,810
17,865 Added 5.72%
330,409 $14.5 Million
Q1 2021

May 12, 2021
BUY
$41.69 - $54.95 $1.12 Million - $1.48 Million
26,964 Added 9.44%
312,544 $15.4 Million
Q4 2020

Feb 12, 2021
BUY
$41.16 - $47.47 $436,049 - $502,897
10,594 Added 3.85%
285,580 $12 Million
Q3 2020

Nov 13, 2020
BUY
$43.36 - $53.53 $358,543 - $442,639
8,269 Added 3.1%
274,986 $12.6 Million
Q2 2020

Aug 13, 2020
BUY
$46.37 - $57.58 $368,270 - $457,300
7,942 Added 3.07%
266,717 $13.4 Million
Q1 2020

May 14, 2020
BUY
$40.22 - $62.0 $1.09 Million - $1.69 Million
27,220 Added 11.76%
258,775 $13.3 Million
Q4 2019

Feb 13, 2020
SELL
$57.95 - $66.61 $32,278 - $37,101
-557 Reduced 0.24%
231,555 $14.3 Million
Q3 2019

Nov 12, 2019
BUY
$60.08 - $88.17 $769,684 - $1.13 Million
12,811 Added 5.84%
232,112 $13.9 Million
Q2 2019

Aug 14, 2019
BUY
$81.3 - $97.35 $557,555 - $667,626
6,858 Added 3.23%
219,301 $18.5 Million
Q1 2019

May 14, 2019
BUY
$69.08 - $105.66 $949,228 - $1.45 Million
13,741 Added 6.92%
212,443 $20.3 Million
Q4 2018

Feb 13, 2019
BUY
$65.41 - $84.65 $1.09 Million - $1.42 Million
16,732 Added 9.19%
198,702 $14.1 Million
Q3 2018

Nov 13, 2018
BUY
$85.46 - $126.37 $988,943 - $1.46 Million
11,572 Added 6.79%
181,970 $15.6 Million
Q2 2018

Aug 14, 2018
BUY
$81.85 - $120.51 $1.48 Million - $2.18 Million
18,078 Added 11.87%
170,398 $19.7 Million
Q1 2018

May 15, 2018
BUY
$57.91 - $92.15 $746,575 - $1.19 Million
12,892 Added 9.25%
152,320 $12.3 Million
Q4 2017

Feb 13, 2018
BUY
$45.65 - $59.37 $82,078 - $106,747
1,798 Added 1.31%
139,428 $8.18 Million
Q3 2017

Nov 14, 2017
BUY
$37.91 - $46.8 $45,871 - $56,628
1,210 Added 0.89%
137,630 $6.44 Million
Q2 2017

Aug 14, 2017
BUY
N/A
136,420
136,420 $4.91 Million

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $198M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email